ALX Oncology Holdings Inc. Common Stock
ALXO Real Time Price USDRecent trades of ALXO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ALXO's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
ALXO Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Combination therapies for treating cancer Sep. 24, 2024
-
Patent Title: Antibodies against signal-regulatory protein alpha and methods of use Mar. 26, 2024
-
Patent Title: Activatable antibodies and methods of use thereof Mar. 26, 2024
-
Patent Title: Constructs having a sirp-α domain or variant thereof May. 02, 2023
-
Patent Title: Methods of treating cancer Mar. 28, 2023
-
Patent Title: Antibodies against signal-regulatory protein alpha and methods of use Aug. 02, 2022
-
Patent Title: Antibodies against signal-regulatory protein α and methods of use Apr. 05, 2022
-
Patent Title: Antibodies against signal-regulatory protein alpha and methods of use Feb. 08, 2022
-
Patent Title: Constructs having a sirp-alpha domain or variant thereof Dec. 28, 2021
-
Patent Title: Constructs having a sirp-alpha domain or variant thereof Jun. 30, 2020
-
Patent Title: Constructs having a sirp-α domain or variant thereof Apr. 16, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ALXO
Number of mentions of ALXO in WallStreetBets Daily Discussion
Recent picks made for ALXO stock on CNBC
ETFs with the largest estimated holdings in ALXO
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ALXO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.